<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1110</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>12610124</PubmedId>
            <Abstract>Protection against Japanese encephalitis virus (JEV) is antibody dependent, and neutralizing antibodies alone are sufficient to impart protection. Thus, we are aiming to develop a peptide-based vaccine against JEV by identifying JEV peptide sequences that could induce virus-neutralizing antibodies. Previously, we have synthesized large amounts of Johnson grass mosaic virus (JGMV) coat protein (CP) in Escherichia coli and have shown that it autoassembled to form virus-like particles (VLPs). The envelope (E) protein of JEV contains the virus-neutralization epitopes. Four peptides from different locations within JEV E protein were chosen, and these were fused to JGMV CP by recombinant DNA methods. The fusion protein autoassembled to form VLPs that could be purified by sucrose gradient centrifugation. Immunization of mice with the recombinant VLPs containing JEV peptide sequences induced anti-peptide and anti-JEV antibodies. A 27-amino-acid peptide containing amino acids 373 to 399 from JEV E protein, present on JGMV VLPs, induced virus-neutralizing antibodies. Importantly, these antibodies were obtained without the use of an adjuvant. The immunized mice showed significant protection against a lethal JEV challenge.</Abstract>
            <ArticleYear>2003</ArticleYear>
            <ArticlePages>3487-94</ArticlePages>
            <ArticleTitle>A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Saini</LastName>
                    <ForeName>Manisha</ForeName>
                </Author>
                <Author>
                    <LastName>Vrati</LastName>
                    <ForeName>Sudhanshu</ForeName>
                </Author>
            </Authors>
            <Affiliations>National Institute of Immunology, New Delhi 110-067, India.</Affiliations>
            <ArticleChemicalList>Antibodies, Viral;Capsid Proteins;Japanese Encephalitis Vaccines;Membrane Glycoproteins;Peptides;Recombinant Fusion Proteins;Viral Envelope Proteins;glycoprotein E, Japanese encephalitis virus</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Viral(blood; immunology); Capsid Proteins(genetics; metabolism); Encephalitis Virus, Japanese(chemistry; immunology; pathogenicity); Encephalitis, Japanese(prevention &amp; control; virology); Immunization; Japanese Encephalitis Vaccines(administration &amp; dosage; immunology); Membrane Glycoproteins(chemistry; immunology); Mice; Molecular Sequence Data; Neutralization Tests; Peptides(immunology); Potyvirus(genetics; metabolism); Recombinant Fusion Proteins(genetics; immunology; metabolism); Viral Envelope Proteins(chemistry; immunology); Virion(chemistry; genetics; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>77</Volume>
                <Issue>6</Issue>
                <Title>Journal of virology</Title>
                <Issn>1098-5514</Issn>
                <MedlineTa>J Virol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Peptide A</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EMEPPFGDSYIVVGRGDKQINHHWHKA</LinearSequence>
                        <StartingPosition>373</StartingPosition>
                        <EndingPosition>399</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAK31640.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11075</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>13366</EpitopeId>
                <ReferenceStartingPosition>373</ReferenceStartingPosition>
                <ReferenceEndingPosition>399</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6C</LocationOfData>
                        <BCellId>15373</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000062</OrganismId>
                                <Age>6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EMEPPFGDSYIVVGRGDKQINHHWHKA</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>399</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Peptide A</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Primary immunization was followed by two booster doses given 3 and 4 weeks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The peptide was fused to Johnson grass mosaic virus coat protein by recombinant DNA methods, and the fusion protein autoassembled to form virus-like particles that were used for immunization. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Endpoint ELISA titers of mice sera were examined.  The antibody response was lower when the peptide was presented on the virus-like particles using a 15 amino acid long linker (Gly-Gly-Gly-Gly-Ser)&lt;sub&gt;3&lt;/sub&gt; between the Johnson grass mosaic virus coat protein and the Japanese encephalitis virus peptide sequence.  The highest response was obtained one week after the second booster.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Japanese Encephalitis virus (JEV)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>15372</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000062</OrganismId>
                                <Age>6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EMEPPFGDSYIVVGRGDKQINHHWHKA</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>399</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Peptide A</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Primary immunization was followed by two booster doses given 3 and 4 weeks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The peptide was fused to Johnson grass mosaic virus coat protein by recombinant DNA methods, and the fusion protein autoassembled to form virus-like particles that were used for immunization. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The antibody response was higher when the peptide was presented on the virus-like particles using a 15 amino acid long linker (Gly-Gly-Gly-Gly-Ser)&lt;sub&gt;3&lt;/sub&gt; between the Johnson grass mosaic virus coat protein and the Japanese encephalitis virus peptide sequence.  The highest response was obtained one week after the second booster.  A similar response was shown when endpoint ELISA titers of mice sera were examined.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Envelope protein</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAK31640.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <BCellId>16230</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000062</OrganismId>
                                <Age>6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EMEPPFGDSYIVVGRGDKQINHHWHKA</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>399</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Peptide A</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Primary immunization was followed by two booster doses given 3 and 4 weeks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The peptide was fused to Johnson grass mosaic virus coat protein by recombinant DNA methods, and the fusion protein autoassembled to form virus-like particles that were used for immunization. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Japanese Encephalitis virus (JEV)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>15371</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000062</OrganismId>
                                <Age>6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EMEPPFGDSYIVVGRGDKQINHHWHKA</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>399</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Peptide A</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Primary immunization was followed by two booster doses given 3 and 4 weeks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The peptide was fused to Johnson grass mosaic virus coat protein by recombinant DNA methods, and the fusion protein autoassembled to form virus-like particles that were used for immunization. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The antibody response was significantly higher when the peptide was presented on the virus-like particles using a 15 amino acid long linker (Gly-Gly-Gly-Gly-Ser)&lt;sub&gt;3&lt;/sub&gt; between the Johnson grass mosaic virus coat protein and the Japanese encephalitis virus peptide sequence.  The highest response was obtained one week after the second booster.  A similar response was shown when endpoint ELISA titers of mice sera were examined.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Peptide A</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EMEPPFGDSYIVVGRGDKQINHHWHKA</LinearSequence>
                                        <StartingPosition>373</StartingPosition>
                                        <EndingPosition>399</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAK31640.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>15374</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000062</OrganismId>
                                <Age>6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EMEPPFGDSYIVVGRGDKQINHHWHKA</LinearSequence>
                                            <StartingPosition>373</StartingPosition>
                                            <EndingPosition>399</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Peptide A</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Primary immunization was followed by two booster doses given 3 and 4 weeks later.  Mice were challenged with 10 times the 50% lethal dose of Japanese encephalitis virus intracerebrally two weeks after the second booster.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The peptide was fused to Johnson grass mosaic virus coat protein by recombinant DNA methods, and the fusion protein autoassembled to form virus-like particles that were used for immunization.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>124</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>6</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>All mice that were immunized with virus-like particles containing the peptide survived, whereas 4 out of 6 mice survived when immunized with virus-like particles containing a 15 amino acid long linker (Gly-Gly-Gly-Gly-Ser)&lt;sub&gt;3&lt;/sub&gt; between the Johnson grass mosaic virus coat protein and the Japanese encephalitis virus peptide sequence.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Other</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Japanese Encephalitis virus (JEV)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide B</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GRGDKQINHHWHKA</LinearSequence>
                        <StartingPosition>386</StartingPosition>
                        <EndingPosition>399</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAK31640.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11075</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>22042</EpitopeId>
                <ReferenceStartingPosition>386</ReferenceStartingPosition>
                <ReferenceEndingPosition>399</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <BCellId>16231</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000062</OrganismId>
                                <Age>6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GRGDKQINHHWHKA</LinearSequence>
                                            <StartingPosition>386</StartingPosition>
                                            <EndingPosition>399</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Peptide B</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Primary immunization was followed by two booster doses given 3 and 4 weeks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The peptide was fused to Johnson grass mosaic virus coat protein by recombinant DNA methods, and the fusion protein autoassembled to form virus-like particles that were used for immunization. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Japanese Encephalitis virus (JEV)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>15376</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000062</OrganismId>
                                <Age>6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GRGDKQINHHWHKA</LinearSequence>
                                            <StartingPosition>386</StartingPosition>
                                            <EndingPosition>399</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Peptide B</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Primary immunization was followed by two booster doses given 3 and 4 weeks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The peptide was fused to Johnson grass mosaic virus coat protein by recombinant DNA methods, and the fusion protein autoassembled to form virus-like particles that were used for immunization. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The antibody response was higher when the peptide was presented on the virus-like particles using a 15 amino acid long linker (Gly-Gly-Gly-Gly-Ser)&lt;sub&gt;3&lt;/sub&gt; between the Johnson grass mosaic virus coat protein and the Japanese encephalitis virus peptide sequence.  The highest response was obtained one week after the second booster.  A similar response was shown when endpoint ELISA titers of mice sera were examined.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Envelope protein</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAK31640.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>15375</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000062</OrganismId>
                                <Age>6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>GRGDKQINHHWHKA</LinearSequence>
                                            <StartingPosition>386</StartingPosition>
                                            <EndingPosition>399</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Peptide B</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Primary immunization was followed by two booster doses given 3 and 4 weeks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The peptide was fused to Johnson grass mosaic virus coat protein by recombinant DNA methods, and the fusion protein autoassembled to form virus-like particles that were used for immunization. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The antibody response was significantly higher when the peptide was presented on the virus-like particles using a 15 amino acid long linker (Gly-Gly-Gly-Gly-Ser)&lt;sub&gt;3&lt;/sub&gt; between the Johnson grass mosaic virus coat protein and the Japanese encephalitis virus peptide sequence.  The highest response was obtained one week after the second booster.  A similar response was shown when endpoint ELISA titers of mice sera were examined.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Peptide B</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GRGDKQINHHWHKA</LinearSequence>
                                        <StartingPosition>386</StartingPosition>
                                        <EndingPosition>399</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAK31640.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>Peptide C</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NHGNYSAQVGASQ</LinearSequence>
                        <StartingPosition>151</StartingPosition>
                        <EndingPosition>163</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAK31640.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11075</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 1</LocationOfData>
                <EpitopeId>44142</EpitopeId>
                <ReferenceStartingPosition>151</ReferenceStartingPosition>
                <ReferenceEndingPosition>163</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>15380</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000062</OrganismId>
                                <Age>6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NHGNYSAQVGASQ</LinearSequence>
                                            <StartingPosition>151</StartingPosition>
                                            <EndingPosition>163</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Peptide C</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Primary immunization was followed by two booster doses given 3 and 4 weeks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The peptide was fused to Johnson grass mosaic virus coat protein by recombinant DNA methods, and the fusion protein autoassembled to form virus-like particles that were used for immunization. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The antibody response was higher when the peptide was presented on the virus-like particles using a 15 amino acid long linker (Gly-Gly-Gly-Gly-Ser)&lt;sub&gt;3&lt;/sub&gt; between the Johnson grass mosaic virus coat protein and the Japanese encephalitis virus peptide sequence.  The highest response was obtained one week after the second booster.  A similar response was shown when endpoint ELISA titers of mice sera were examined.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Envelope protein</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>AAK31640.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>15379</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000062</OrganismId>
                                <Age>6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NHGNYSAQVGASQ</LinearSequence>
                                            <StartingPosition>151</StartingPosition>
                                            <EndingPosition>163</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Peptide C</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Primary immunization was followed by two booster doses given 3 and 4 weeks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The peptide was fused to Johnson grass mosaic virus coat protein by recombinant DNA methods, and the fusion protein autoassembled to form virus-like particles that were used for immunization. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The antibody response was significantly higher when the peptide was presented on the virus-like particles using a 15 amino acid long linker (Gly-Gly-Gly-Gly-Ser)&lt;sub&gt;3&lt;/sub&gt; between the Johnson grass mosaic virus coat protein and the Japanese encephalitis virus peptide sequence.  The highest response was obtained one week after the second booster.  A similar response was shown when endpoint ELISA titers of mice sera were examined.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Peptide C</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NHGNYSAQVGASQ</LinearSequence>
                                        <StartingPosition>151</StartingPosition>
                                        <EndingPosition>163</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAK31640.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <BCellId>16232</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000062</OrganismId>
                                <Age>6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>NHGNYSAQVGASQ</LinearSequence>
                                            <StartingPosition>151</StartingPosition>
                                            <EndingPosition>163</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAK31640.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11075</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Peptide C</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Primary immunization was followed by two booster doses given 3 and 4 weeks later.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The peptide was fused to Johnson grass mosaic virus coat protein by recombinant DNA methods, and the fusion protein autoassembled to form virus-like particles that were used for immunization. .</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Japanese Encephalitis virus (JEV)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11075</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

